38228 Car-t admn autologous
Surgery
Also known as: CAR-T infusion, CAR-T administration
Infusion of autologous chimeric antigen receptor T-cells into the patient for therapeutic treatment of hematologic malignancy.
Clinical Context
Therapeutic infusion of patient's own engineered CAR-T cells for treatment of leukemias and lymphomas.
RVU Breakdown
| Work RVU | 3.00 |
| Practice Expense RVU | 6.35 |
| Malpractice RVU | 0.20 |
| Total RVU | 9.55 |
Est. Medicare Payment
$318.97
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.